Title:
Japanese university uses iPS cells in first treatment of spinal cord injury
Published:
The Japan Times, 14 January 2022
From the article:
Keio University in Tokyo said Friday it has started the world’s first clinical test using induced pluripotent stem cells, or iPS cells, to treat patients with spinal cord injuries. In the study commenced in December, the university will eventually transplant cells derived from iPS cells to four patients who between two to four weeks earlier lost motor and sensory function after sustaining injuries when playing sport or in traffic accidents.